Mylan launches generic version of seizure drug
Mylan Inc. said Monday it started selling a generic version of Abbott Laboratories' anti-seizure treatment Depakote Sprinkles capsules.
The Canonsburg, Pa., generic drugmaker said it is selling 125-milligram capsules of divalproex sodium, the drug's generic name.
Mylan said U.S. sales for divalproex sodium capsules totaled about $89 million in the 12 months that ended March 31, citing IMS Health.
Shares of Mylan fell 51 cents, or 2.1 percent, to close Thursday at $23.31.